| Spirig HealthCare AG - Lorazepam Spirig HC 2.5 mg, Tabletten |
| 69682 | | 02 | | Lorazepam Spirig HC 2.5 mg | | Tabletten | | N05BA06 | | Lorazepam | | 22.08.2024 | | |
|
| Composition |
| lorazepamum 2.5 mg, lactosum monohydricum 122.8 mg, cellulosum microcristallinum, polacrilinum kalicum, magnesii stearas, E 172 (flavum), pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Lorazepam | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lorazepam | 2.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Lactose Monohydrate | 122.8 mg | | | Magnesii Stearas | | | | Polacrilinum Kalicum | | | | Pro Compresso | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 20 | 2.75 | 12.20 | B | LS | Non | | 004 | 50 | 6.29 | 16.05 | B | LS | Non |
|
